conservation of these residues ( Fig. 3) (14, 15) . In PleD, the most well-investigated diguanylate cyclase for which a crystal structure is available, the guanine base is bound in a pocket with N335 and D344 as key contact residues, curtailed by apolar side chains of L294, F331, and L247. D/E is the catalytic base, while K332 stabilizes the transition state. All those residues are well conserved in catalytically competent diguanylate cyclases (Fig. 2) .
Nonfunctional GGDEF domains are usually characterized by a degenerate GGDEF motif, as any mutation within the GGDEF motif of catalytically active GGDEF domain proteins abolishes the catalytic activity, although there are exceptions. For example, the GGDEF domain protein of Staphylococcus aureus and Staphylococcus epidermidis with a well-conserved GGDEF motif has been experimentally proven to be nonfunctional (16) . The structural basis of the nonfunctionality of staphylococcal GGDEF domains still remains an enigma. As to alteration in the signature motif, it is fairly common that GGDEF domains contain a degenerate GG(D/E)EF motif with the first G not conserved. Recent experimentally characterized proteins with a G¡A or G¡S substitution still exhibit significant functionality, demonstrating unexpected flexibility in the GGDEF containing active-site hairpin ( Fig. 2) (17) (18) (19) .
Besides the gross classification into catalytically active and nonactive GGDEF domains, the inhibitory site (I-site), designated by the central signature motif RXXD, is another functional feature which characterizes the activity profile (14, 20) . The I-site, which is formed at an intra-or intermolecular interface bridged by a cyclic di-GMP dimer, variably extends beyond the central conserved RXXD cyclic di-GMP binding motif and mediates allosteric noncompetitive product inhibition, through feedback control of cyclic di-GMP synthesis (20, 21) . The RXXD motif is absent in a proportion of GGDEF domains; alternative mechanisms to control cyclic di-GMP synthesis have been described for some of these proteins (6, 22, 23) . A second recently discovered function of the I-site is the participation in protein-protein interaction with a cyclic di-GMP receptor, which ensures a stringent specificity of cyclic di-GMP signaling even in the presence of cyclic di-GMP production (21) . In divergent GGDEF domain proteins (see below), a retained I-site in catalytically nonfunctional GGDEF domains converts these domains into cyclic di-GMP receptors (24) (25) (26) (27) . It should be noted that the enzymatic activity of the GGDEF domain can also be positively regulated by cooperative binding of the GTP substrate (19) .
Some GGDEF domains have diverged to be enzymatically nonfunctional. These nonfunctional GGDEF domains can act as sensor domains that bind the substrate GTP, thereby allosterically regulating the enzymatic activity of a C-terminal EAL phosphodiesterase (28) . In this way, the degenerate GGDEF motif is involved in allosteric control (20, 29) . A surprisingly high catalytic plasticity has been demonstrated, as a highly degenerate GGDEF domain has been shown to display ATPase activity, albeit at suboptimal levels (30) .
ALTERNATIVE CYCLIC DINUCLEOTIDES SYNTHESIZED BY GGDEF DOMAIN PROTEINS
A hallmark of binding of nucleotide and sugar derivatives to proteins is the low stringency of the specificity of the binding site. Accordingly, alteration of a few amino acids can alter the substrate specificity of nucleotides and sugars. Although it is the common perception that cyclic di-GMP synthases can be readily identified in bacterial genomes as being members of the GGDEF domain superfamily, GGDEF domain proteins that predominantly synthesize cyclic GMP-AMP, in parallel with cyclic di-GMP and cyclic di-AMP, have recently been identified (31) . The relative specificity of cyclic GMP-AMP synthase activity as opposed to stringently using GTP as the substrate on this specific protein scaffold is determined by the amino acid serine, which has replaced aspartate at position 344 (designation according to PleD sequence), a key contact residue in the base binding pocket. As the exchange of aspartate for serine in an established diguanylate cyclase did not lead to the conversion into a cyclic GMP-AMP synthase, additional features of the protein scaffold must also contribute to substrate specificity.
SPECIFICITY IN REGULATORY ACTION
In general, GGDEF domains encoded by a single genome are functional paralogues, which have a low amino acid sequence identity/similarity, below 40%, while orthologues with identical domain structure and high sequence identity can be found even in distantly related species (32) . One of the hallmarks of cyclic di-GMP signaling is a relative or absolute specificity of a phenotypic output of an individual chromosomally encoded GGDEF domain protein. This specificity is partly explained by the close proximity of signal production/degradation with receptor and/or effector proteins mediated through protein-protein interactions, a first example being the involvement of the I-site of a GGDEF domain in interaction with an EAL domain cyclic di-GMP receptor (21, 33) . Interactions between the EAL domain protein YciR and diguanylate cyclase YdaM control a key step in E. coli biofilm formation through a suggested modulation of localized cyclic di-GMP levels (34) . Functionality is also provided, however, by specific protein-protein interactions that are independent of the catalytic activity (19, 35) . In this case, the XXDXDX motif, which is highly conserved in GGDEF domains, is required for the interaction with the HD-GYP domain. HD-GYP-GGDEF complex formation serves to control motility through recruitment of a PilZ domain protein and interaction with the pilus biogenesis machinery (35, 36) . Overall, these data indicate that GGDEF domain proteins possess several protein interaction interfaces which participate in the formation of supramolecular complexes.
FUNCTIONAL DIVERSIFICATION OF THE EAL DOMAIN
The EAL domain was the first identified cyclic di-GMP-specific phosphodiesterase and remains the most well characterized ( Fig. 4 and 5 ; see also Fig. S1 in the supplemental material) (2, 37, 38) . The product of EAL phosphodiesterase activity is the dinucleotide 5=-pGpG, while hydrolysis of 5=-pGpG into GMP is considered to be too slow to be physiologically relevant. EAL phosphodiesterases require a divalent cation for enzymatic activity, which in most cases is a Mg 2ϩ or Mn 2ϩ ion, while Ca 2ϩ and Zn 2ϩ efficiently inhibit the enzymatic activity (39, 40) . Catalytically active EAL domains usually have a high substrate affinity in the physiological nanomolar range, and cyclic di-GMP binding can increase the dimerization affinity (41) . Although monomers can be catalytically active, dimerization substantially enhances protein stability and catalytic activity (37) .
KEY RESIDUES FOR ACTIVITY
Systematic alanine substitutions of conserved signature amino acids have given insights into the catalytic mechanism, even before a crystal structure had become available (42, 43) . That work showed that the EAL motif is part of a larger conserved signature motif that is required for catalytic activity, including amino acids required for binding of divalent cations, the substrate, and catalysis. In addition, a flexible loop (loop 6) extensively characterized in (␤/␣) 8 barrel proteins (see below) mediates dimerization and controls substrate and cation binding, thus being required for catalytic activity (42, 44) . The findings from this mutagenesis study enabled the differentiation of EAL domains in three classes, catalytically active, potentially catalytically active, and catalytically inactive EAL domains (32, 42) , thus facilitating the prediction of the function of further EAL domains. Based on the functional characterization of additional EAL domains, further subclassifications can be made (Fig. 4) .
The crystal structures of several EAL domain-containing proteins revealed that these proteins possess a protein fold variant of the (␤/␣) 8 TIM-barrel structure, arranged as eight alternating alpha-helices and beta-strands (Fig. 5) (44) . This arrangement of secondary structures is found in over 50 diverse protein superfamilies (45) . The functionality of this highly conserved arrangement of secondary structures is highly flexible, as these protein families bind different substrates and catalyze different reactions. In case of the light-inducible phosphodiesterase Blrp1 of Klebsiella pneumoniae, interdomain interaction between the sensor domain and a nonconserved connector in the EAL domain of only four amino acids in length controls the catalytic activity in response to light (Fig. 5A) (44) .
CLASSIFICATION OF DIVERGENT DOMAIN MEMBERS
As with the GGDEF domain, the EAL domain superfamily contains diverged members. Most EAL domains are class I EAL domains, which possess a N-terminal signaling domain and feature substantial, but still suboptimal, catalytic activity in the nonactivated state, requiring the correct positioning of conserved loop 6 (42, 44) . Class II EAL domains potentially possess catalytic activity with deviations of some amino acids from the conserved signature motifs; they are most poorly characterized. Of note, catalytically active EAL-only domain proteins comprise a specific subgroup within the class II family. Class III EAL domains can already be recognized by bioinformatic analysis to be catalytically inactive, since class III domains possess deviations from the conserved signature motifs of active enzymes in several determinative positions. Nevertheless, some class III domains can still bind cyclic di-GMP, thus serving as cyclic di-GMP receptors (class IIIa), whereas others are unable to bind the dinucleotide (class IIIb) (Fig. 5B) .
Cyclic di-GMP binding and nonbinding EAL domains cannot be distinguished with certainty (Fig. 4) . However, in both cases, several conserved signature amino acids are missing, and loop 6 is not conserved. Binding of cyclic di-GMP to a receptor EAL domain allosterically controls subsequent events. In the conserved Lap system with the GGDEF-EAL receptor LapD, interactive inside-out/outside-in signals mediated by the HAMP domain couple cytoplasmic cyclic di-GMP binding to reinforcement of periplasmic protein-protein interactions controlling, e.g., periplasmic proteolysis of cell surface proteins (46, 47) . Interestingly, homologous GGDEF-EAL receptors have variations in their cyclic di-GMP binding sites and bind cyclic di-GMP in different conformations, which reflects the structural polymorphism of this second messenger (48, 49) , as well as binding site flexibility (Fig. 5C) (50) . Such polymorphisms make it still challenging to predict cyclic di-GMP binding residues by bioinformatics.
Catalytically inactive noncyclic di-GMP binding EAL proteins function solely through protein-protein interactions. Several well-investigated class IIIb proteins of Escherichia coli and Salmonella enterica serovar Typhimurium, YdiV and Salmonella-specific STM1697, bind to the major flagellin regulator FlhDC with apparently similar but highly distinct interfaces (51) (52) (53) . Furthermore, the class IIIb protein YdiV interacts in complex with FlhDC with the ClpXP protease, guiding FlhDC for degradation (54) , and it regulates other physiological traits besides motility (55) .
REGULATION OF DUAL-FUNCTION DIGUANYLATE CYCLASE PHOSPHODIESTERASES
Of particular complexity is the regulation of the activity of GGDEF-EAL domain proteins in cases where both domains are catalytically functional (56) . Notably, the three DGCs and three PDEs of Komagataeibacter xylinus that affect cellulose production, the first biological function recognized to be affected by cyclic di-GMP signaling, are GGDEF-EAL domain proteins, and both domains are predicted to be functional by bioinformatics analysis (39) . Differential regulation of the catalytic activity of these domains can include allosteric regulation by ligand binding, signal perception, or protein-protein interactions, which favor one catalytic activity over the other (7, (57) (58) (59) (60) , but could also include a combination of regulatory mechanisms, such as proteolytic cleavage in combination with signal perception (61) . This points to a multifactorial regulation of catalytic activity in vivo. However, catalytically active domains can even predominantly affect certain aspects of physiology through protein-protein interactions. For example, the GGDEF-EAL phosphodiesterase YciR of E. coli affects the expression of csgD, a major biofilm regulator, through interaction with a DGC and a transcriptional regulator, which inhibits biofilm formation (34) .
PHOSPHODIESTERASE INVOLVED IN pGpG DEGRADATION
The observation that the EAL domain hydrolyzes cyclic di-GMP into 5=-pGpG ( Fig. 1 ) has raised the question of the possible cellular role and fate of this dinucleotide product (62) . As an inhibitor of the enzymatic activity of particular EAL domain proteins, this molecule potentially impinges on cyclic di-GMP levels and signaling. Furthermore, it has been suggested that this nanoRNA (i.e., RNA oligonucleotide of Յ5 nucleotides) is a signaling molecule in its own right and is involved in the initiation of transcription by RNA polymerase (63) . Two classes of enzymes are implicated in 5=-pGpG degradation: a subgroup of HD-GYP domain phosphodiesterases that can hydrolyze both cyclic di-GMP and 5=-pGpG (see below), and the oligoribonuclease Orn, recently identified as the primary degradative enzyme for 5=-pGpG in Pseudomonas aeruginosa (64, 65) . Homologues of Orn are widely distributed in bacteria, although Cohen and colleagues (65) identified over 200 species that lack an Orn homolog but have EAL and HD-GYP domain proteins, as well as over 100 species that lack both an Orn homolog and EAL domain proteins but have HD-GYP domain proteins. Thus, in some bacteria, HD-GYP domain proteins may influence cyclic di-GMP levels both directly, by hydrolysis of the nucleotide, and indirectly, by preventing product inhibition of the activity of EAL domain enzymes.
FUNCTIONAL DIVERSIFICATION OF THE HD-GYP DOMAIN
There are fewer studies of HD-GYP domain proteins than those of the GGDEF and EAL domains. Although well-studied model organisms harbor mostly EAL domain phosphodiesterases, the HD-GYP domain is one-third as abundant throughout the phylogenetic tree (https://www.ncbi.nlm.nih.gov/Complete_Genomes/c-di-GMP.html). The prototype of an HD-GYP domain protein is the response regulator RpfG from Xanthomonas campestris (36, 66) . This protein is part of a two-component system that affects the expression of multiple virulence functions in this plant pathogen (67, 68) . In vitro, RpfG converts cyclic di-GMP to GMP via the intermediate 5=-pGpG dependent on Mn 2ϩ (66, 69 ). An alanine substitution within the signature HD dyad leads to a loss of both enzyme activity and regulatory action (66) . In contrast, although alanine substitutions in the signature GYP motif have little or no effect on enzyme activity, they do counteract the interaction of RpfG with particular GGDEF domain proteins to modulate a specific subset of RpfG-mediated phenotypes (35, 66, 70) .
DIVERSITY IN METAL BINDING
The crystal structure of the enzymatically active HD-GYP phosphodiesterase from Persephonella marina EX-H1 (PmGH) unexpectedly showed a trinuclear Fe center with iron in two redox states, as Fe(II) and central Fe(III), buried at the bottom of the cavity forming the c-di-GMP binding site (Fig. 6) (71) . In general, the HD domain superfamily of enzymes has been shown to catalyze phosphomonoesterase and phosphodiesterase reactions, depending on their catalytic metal center being mono-or binuclear, respectively. Variations in the metallic center of the HD-GYP domain were seen in the structure of the unconventional catalytically inactive Bd1817 from Bdellovibrio bacteriovorus (72) , and PA4781, a two-component regulatory protein from Pseudomonas aeruginosa (73) , which harbor binuclear metal centers, although of a distinct nature.
A phylogenetic comparison of HD-GYP domains showed a distinct separation into two evolutionary groups independent of the type of associated regulatory and/or sensory domains (71) , with seven out of the eight PmGH metal ligand residues shared ( Fig. 7) (71) . The variable ligand which corresponds to E185 in PmGH is embedded in the signature motif E/D-T-G for the PmGH subfamily. E185 has been predicted to be determinative for a three-metal center valency (71, 74) . Conversely, the other subfamily primarily presents a tyrosine or phenylalanine (Y/F) and lacks a unique signature. The separation of HD-GYP proteins into these two subfamilies is not entirely clear-cut, though ( Fig. 7) (73, 75) . For example, RpfG from X. campestris, despite phylogenetically clustering within the E/D-T-G subgroup, aligns a glycine in place of the E/D residue, as well as variation in an H-site metal ligand (Fig. 7) . Thus, RpfG is more likely to possess a binuclear metal ion center.
Recent work has provided evidence that the differences in the occupancy of the metal site and the redox status affect catalysis (74) . The activity of VCA0681 requires Fe(II) at the bimetallic center, and derivatives with Fe(III) are inactive, suggesting that the activity of this protein is redox regulated (76) . Also, isolated TM0186 from Thermotoga maritima with two Fe(III) atoms is inactive; reduction to Fe(II) enables the enzyme to generate 5=-pGpG but not GMP. Additional supplementation with either Mn(II) or Fe(II) leads to the production of GMP. The phylogenetic clustering of TM0186 within the E/D-T-G subgroup of HD-GYP domain proteins suggests that it has a trimetallic center. Furthermore, a variant protein with an alanine substitution of the glutamate generates only 5=-pGpG as a product. The findings point to the association of a trimetallic center with the ability to generate GMP from 5=-pGpG. Also, the action of HD-GYP domains in converting 5=-pGpG to GMP suggests regulation by the intracellular availability of metals and metal site occupancy. Finally, catalytically inactive SO2541 HnoD from Shewanella oneidensis and PA2572 from P. aeruginosa are variant at the HD dyad (SE and YN, respectively) and have only 1 conserved residue involved in metal chelation (77, 78) ; as a result, these proteins may exert their effect through protein interactions involving the GYP motif (77, 78) .
DIVERSITY IN SUBSTRATE BINDING AND CATALYSIS
Determination of the structure of PmGH in complex with the substrate cyclic di-GMP and final reaction product, GMP, has revealed the mode of binding and shed light on the possible catalytic mechanism (71, 79) . Adequate space is available for the substrate to bind and both hydrolysable phosphates to interact with the metal center to sequentially hydrolyze cyclic di-GMP to GMP. Cyclic di-GMP is bound in a cis confor- mation (71) , in contrast to the more extended conformation observed when cyclic di-GMP is bound to EAL domain proteins (80) or predicted in binding to the HD-GYP domain protein PA4108 (81) .
The structural analysis of the PmGH-cyclic di-GMP complex shows that the bound cyclic dinucleotide interacts with the central (M-site) Fe(III) and is involved in diverse hydrogen bonds and hydrophobic interactions (Fig. 6) . As in RpfG, in PmGH alanine substitutions of six residues involved in metal binding in addition to the HD dyad (H221 and D222) (Fig. 7) essentially abolish or markedly reduce the phosphodiesterase activity. Alanine mutations of other conserved residues near the metal center (D183, D308, and K225) have a similar impact on activity (71) . Alanine substitutions of residues implicated in cyclic di-GMP recognition do not, however, result in a substantial decrease in catalytic activity (71) . The proposed enzymatic mechanism is that M-site Fe(III) directly interacts with a nonbridging oxygen of one of the scissile phosphate diesters of cyclic di-GMP to provide a strong Lewis acid catalyst, whereas a metal-activated bridging hydroxide ion of the M-H Fe pair is the likely nucleophile for the hydrolysis of the scissile bond (71) . The occurrence of a hydroxide ion-bridging ligand is consistent with the metal-ligand bond lengths (72, 82) . The structure does not reveal how the O 3 = leaving group is protonated, however.
The structure of PA4781 reveals potential steric hindrance of cyclic di-GMP binding by a glutamate at position 314 (73) . Accordingly, the purified enzyme has a relatively low affinity for cyclic di-GMP (K m , ϳ120 M) compared to 5=-pGpG (K m , ϳ27 M). In other enzymatically active HD-GYP domain proteins, position 314 is occupied by an alanine (Fig. 7) , and an E314A variant of PA4781 shows substantially enhanced affinity for cyclic di-GMP (81) . Detailed kinetic analyses indicate that PA4781 has low enzymatic activity but hydrolyzes 5=-pGpG more effectively than cyclic di-GMP (81). Although similar kinetic experiments on other HD-GYP domain proteins have not been reported, the available evidence suggests that differences in the relative activity against 5=-pGpG compared to cyclic di-GMP do occur (66, 69, 71, 76, 77, 83, 84) .
STRUCTURAL INSIGHTS INTO THE MULTIFUNCTIONAL ROLES OF HD-GYP DOMAINS
A sequence-based analysis identified the GYP signature motif of HD-GYP proteins as part of a larger widely conserved motif, HHEXXDGXGYP (66). The PmGH structure suggests an extension of this consensus motif to HHEXXDGXGYPXXXXXXXI, to include a conserved isoleucine residue (I294 in PmGH) that stabilizes the structure of the loop by hydrophobic interactions with G284 from the GYP motif (71) . The structural conservation of the GYP loop (Fig. 6 ) (73) between PmGH and PA4781 suggests that it is integral to the functions(s) of HD-GYP domain proteins. The GYP motif is critical for protein-protein interactions of RpfG with specific GGDEF domain proteins in X. campestris but is not necessary for the phosphodiesterase activity (66) .
The available evidence suggests that the HD-GYP domain of RpfG can also interact with proteins of other classes, including the transcriptional regulator NtrC (36, 85) . Furthermore, the enzymatically inactive HD-GYP domain response regulator HnoD can inhibit the activity of the EAL domain response regulator HnoB to regulate cyclic di-GMP levels in Shewanella oneidensis (77) . The mechanistic basis of this inhibition is not known. Different HD-GYP domain proteins within the same organism may interact with different partners in vivo, although this remains to be tested experimentally.
The structure of the PmGH HD-GYP complex with cyclic di-GMP reveals that Y285 of the GYP motif is placed inside the substrate binding pocket, where it H-bonds to cyclic di-GMP (Fig. 6 ). This presents a conundrum for the action of RpfG. If GGDEF domains interact directly with Y285, they need to intercalate with the inner side of the HD-GYP nucleotide binding pocket. This would prevent cyclic di-GMP binding and phosphodiesterase activity, although such effects have not been observed in vitro (35) . An intriguing alternative is that RpfG involvement in protein-protein complexes is determined not only by cyclic di-GMP binding but also by conformational alterations associated with cyclic di-GMP degradation, which would be "reported" via the GYP loop. In this way, RpfG would act as a trigger enzyme for protein complex formation and regulation, similar to what is suggested for the EAL domain protein YciR of Escherichia coli (34) . However, mutation of the HD dyad of the HD-GYP domain of RpfG does not significantly affect its in vivo interaction with GGDEF domain proteins, as revealed by fluorescent resonance energy transfer (FRET) analysis (35) . Only further work can reveal whether particular regulatory actions of HD-GYP domain proteins occur independently of their ability to bind or hydrolyze cyclic di-GMP or 5=-pGpG.
FURTHER SUBSTRATES FOR HD-GYP DOMAIN PROTEINS
In addition to cyclic di-GMP, bacteria have been shown to utilize cyclic di-AMP and, most recently, the dinucleotide 3=3=-cyclic GMP-AMP as intracellular signal molecules. The 3=3=-cyclic GMP-AMP molecule was discovered in Vibrio cholerae as a regulator of chemotaxis and of factors contributing to colonization of the intestine (86) . A screen of potential phosphodiesterases for 3=3=-cyclic GMP-AMP from V. cholerae identified three HD-GYP domain proteins, VCA0210, VCA0681, and VCA0931, which were capable of hydrolysis of the cyclic dinucleotide into 5=-pApG, with VCA0681 having an additional 5=-nucleotidase activity to generate 5=-ApG (87) . The nucleotidase and phosphodiesterase activities were associated with the HD and HD-GYP domains, respectively, which are present in tandem (87) . All three proteins hydrolyze 3=3=-cyclic GMP-AMP specifically, with no activity against other cyclic GMP-AMP forms with different phosphodiester linkages, to include the mammalian innate immunity regulator 2=3=-cyclic GMP-AMP. Variant VCA0681 proteins with alanine substitutions in the signature HD dyad and GYP motif have no detectable activity (87) , in contrast to the role of the GYP motif in PmGH and RpfG (70, 71) .
FUNCTIONAL DIVERSIFICATION OF CYCLIC DI-AMP PHOSPHODIESTERASES
The functional diversification also extends to other cyclic dinucleotide signaling networks. As the currently most prominent example, DHH/DHHA1 proteins usually function as phosphatase or phosphodiesterases for hydrolyzing a wide variety of substrates that range from pyrophosphate to single-stranded DNA (ssDNA). The substrate specificity of DHH/DHHA1 enzymes is usually governed by the DHHA1 domain rather than the DHH domain. A bioinformatics search of potential phosphodiesterases for cyclic di-AMP, a universally essential cyclic dinucleotide second messenger in Gram-positive bacteria (88, 89) , led to the discovery of a DHH domain protein (YybT or GdpP) from Bacillus subtilis as a cyclic di-AMP phosphodiesterase (30) . GdpP is a metal ion-dependent phosphodiesterase that breaks down cyclic di-AMP into 5=-pApA at physiologically relevant substrate (micromolar) concentrations. In accordance with its specificity toward cyclic di-AMP, the DHHA1 domain of GdpP does not share significant sequence homology with the DHHA1 domains of other DHH/DHHA1 proteins. Importantly, a number of Arg residues critical for the binding of polyphosphate, RNA, or ssDNA in other DHHA1 domain proteins (e.g., RecJ and YtqI) are not conserved in YybT. Another DHH/DHHA1 protein (Pde2) that lacks the PAS and GGDEF domains of GdpP and degrades cyclic di-AMP into AMP was discovered in Streptococcus pneumoniae (90) . Pde2 is an ortholog of B. subtilis YtqI (also named NrnA) that was claimed to be responsible for degrading nanoRNA (RNA oligonucleotides of Յ5 nucleotides) and dephosphorylating pAp to AMP (91, 92) .
In addition to the DHH/DHHA1 proteins, a subfamily of HD domains possesses cyclic di-AMP phosphodiesterase activity. The first example is the Listeria monocytogenes protein PgpH (93) . Biochemical and structural studies revealed binding of cyclic di-AMP with high affinity (K d [dissociation constant], 0.3 to 0.4 M) and hydrolysis to 5=-pApA in the presence of divalent metal ions, such as Mn 2ϩ and Fe 2ϩ .
The discovery of the DHH/DHHA1-and HD domain-based phosphodiesterases for degrading cyclic di-AMP mirrors the converging evolution of the EAL and HD-GYP domains involved in cyclic di-GMP degradation. Although the structural basis for the recognition of cyclic di-AMP by the PDEs remains to be fully defined, the crystal structure of the standalone DHH/DHHA1 protein Rv2837c in complex with the hydro-lytic intermediate 5-pApA suggests that a set of residues from both DHH and DHHA1 domains contribute to the binding of cyclic di-AMP (94) . Even assuming that only two families of cyclic di-AMP phosphodiesterases are found in nature, identification of the members of the two families by bioinformatics should still proceed with caution, and experimental validation is necessary.
CONCLUDING REMARKS
As outlined above, diversity in the functions of the GGDEF, EAL, and HD-GYP domains is evident in terms of enzymatic activity, the ability to synthesize or degrade alternate dinucleotides, as well as in interactions with other proteins. This functional diversity certainly extends to other cyclic dinucleotide turnover proteins, such as the DHH/DHHA1 enzymes. Further biochemical and structural work is required to gain knowledge of the molecular bases for the substrate specificity or preference. Work on stringent cyclic mononucleotide synthases shows that quite limited variations give rise to different specificities; cyclic GMP synthases can be experimentally changed to cyclic AMP synthases, and vice versa, by just two or three amino acid exchanges (95, 96) . On the other hand, relaxed enzymes can produce several different cyclic nucleotides (97) . In addition, a three-amino-acid replacement in the human cyclic dinucleotide synthase cyclic GMP-AMP synthase (cGAS) changes the phosphodiester linkage specificity so that 3=3= cyclic GMP-AMP rather than the noncanonical 2=3= cyclic GMP-AMP is synthesized (98) . The three new residues incorporated were the determinative amino acids in DncV, a bacterial homolog of cyclic GMP-AMP synthase (98) . Indeed, ancient cGAS is a 3=3= cyclic GMP-AMP synthase (99). As outlined above, distinct GGDEF domain proteins that have been shown to produce cyclic GMP-AMP (31) and some HD-GYP domain phosphodiesterases can have cyclic GMP-AMP hydrolytic activity (87) . Changes in substrate specificity similar to those within the GGDEF and HD-GYP domain protein families could also occur within the EAL domain. In addition, novel enzymes with cyclic dinucleotide turnover activity might be recognized. Recently, CpdB, which displays a diffusionlimited reaction rate in 3=-AMP hydrolysis, was also shown to hydrolyze cyclic di-AMP with a reasonable turnover rate (100). With the current stage of knowledge, it thus appears difficult to assign substrate specificity and product outcome with certainty by bioinformatics. Thus, current species-specific nomenclatures might limit comparisons to distantly related species, which frequently harbor orthologous proteins, while functional paralogues of dinucleotide turnover proteins dominate within a species. The elucidation of the structures of cyclic di-GMP turnover domains in complex with other cyclic di-GMP turnover domains and other interacting proteins will also be necessary to provide a deeper understanding of the regulatory action of the diversity of these families of signaling proteins and to fully explore their true functions. This is certainly the case for those proteins that may be multifunctional and which may regulate different functions through protein-protein interactions and modulation of cyclic di-GMP levels.
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